Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migalastat Phase 2 in Fabry Disease
NCT00283959Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- Jun 2006
- Primary completion
- May 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Primary endpoint: Number Of Participants Who Experienced Severe Treatment-emergent Adverse Events. Started Jun 2006; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00283959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283959.